| Financial Year |
March 31 2023 |
| Monetary Funds |
140,005,969,096.16 |
| Held-for-trading Financial Assets |
14,609,346.06 |
| Notes Receivable |
4,159,783.51 |
| Accounts Receivable |
8,597,967,350.81 |
| Advances to Suppliers |
62,414,648,226.11 |
| Other Receivables |
280,307,989,524.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
74,715,682.05 |
| Dividend Receivable |
60,010,250.30 |
| Inventories |
877,709,488,834.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,494,816,976.37 |
| Total Current Assets |
1,401,049,096,094.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
128,292,638,029.13 |
| Investment Properties |
99,388,817,984.34 |
| Fixed Assetes |
17,170,809,088.95 |
| Under-construction Projects |
2,168,910,257.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
296,962,083.10 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,613,583,259.74 |
| R&D expenses |
-- |
| Goodwill |
5,400,800,865.99 |
| Long-Term Deferred and Prepaid Expenses |
8,317,613,361.46 |
| Deferred Income Tax Assets |
37,696,395,221.79 |
| Other Non-Current Assets |
6,391,981,067.02 |
| Sub-Total of Non-Current Assets |
342,029,498,440.32 |
| Total Assets |
1,743,078,594,535.06 |
| Short-Term Loans |
3,100,513,777.18 |
| Trading Financial liabilities |
191,792,000.00 |
| Notes Payable |
548,375.54 |
| Accounts Payable |
256,886,478,859.97 |
| Accounts Received In Advance |
1,312,468,781.64 |
| Employee Compensation Payable |
5,019,805,349.67 |
| Taxes Payable |
29,295,746,337.16 |
| Interest Payable |
48,454,429.03 |
| Dividend Payable |
584,519,837.34 |
| Other payables |
174,296,055,948.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,656,946,601.74 |
| Other Current Liabilities |
42,710,232,755.60 |
| Sub-Total of Current Liabilities |
1,059,822,714,802.91 |
| Long-term Loans |
199,091,772,358.91 |
| Bonds Payable |
62,361,456,157.33 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
431,556,184.29 |
| Deferred Income Tax Liabilities |
1,121,622,007.64 |
| Other Non-Current Liabilities |
1,138,191,038.74 |
| Sub-Total of Non-Current Liabilities |
285,750,021,476.63 |
| Total Liabilities |
1,345,572,736,279.54 |
| Paid-In Capital(Or Share Stock) |
11,930,709,471.00 |
| Capital Surplus |
23,826,563,235.83 |
| Surplus Reserve |
117,743,677,081.49 |
| LESS:Treasury Stock |
1,291,800,290.12 |
| Undistributed Profits |
99,459,704,105.80 |
| Minority Stockholder's Interest |
151,493,562,292.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
246,012,295,962.94 |
| Owner's Equity（Stockholder's Equity） |
397,505,858,255.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,743,078,594,535.06 |
